Armin Schulz
Born in Mönchengladbach, he studied business administration in the Netherlands. In the course of his studies he came into contact with the stock exchange for the first time. He has more than 25 years of experience in stock market business.
After graduating, he worked as an IT consultant for a listed company before becoming self-employed, during which time he worked for various DAX-listed companies and a large Swiss insurance company, among others.
Since 2009, he has been exclusively involved in the capital markets, where he was able to gain experience as a day and swing trader, in investor relations and at board level. He was able to live out his passion for numbers in the controlling department of a securities trading house.
For him, fundamental analysis paired with the correct reading of the price action of a market provides the basis for successful trading.
Commented by Armin Schulz
Commented by Armin Schulz on August 28th, 2025 | 07:15 CEST
The BioNxt Solutions formula: How a simple idea can turn into a billion-dollar business – Without high risk
In the pharmaceutical industry, promising active ingredients often fail due to a simple problem, such as administration. Canadian biotech company BioNxt Solutions has taken on precisely this challenge. With a smart platform for oral dissolvable films and patches, the Vancouver-based innovator could not only make life easier for patients but also open up a lucrative growth opportunity for investors. We took a closer look at the promising technology behind it.
Read
Commented by Armin Schulz on August 28th, 2025 | 07:00 CEST
The silver boom: What investors need to know about Intel, Silver North Resources, and Xiaomi
Silver is experiencing a historic surge, driven by the megatrends of our time. Industrial demand is exploding, fueled by the tech revolution, the green energy transition, and the electrification of our everyday lives. This indispensable commodity, the best electrical conductor, is found in every smartphone, every electric vehicle, and every solar cell. Supply can barely keep up. Today, we are examining two electronics companies that face high silver prices and analyzing a silver company that is in an exciting phase.
Read
Commented by Armin Schulz on August 27th, 2025 | 07:15 CEST
Benefit from the hydrogen boom: The most promising developments at Nel ASA, dynaCERT, and Daimler Truck
The hydrogen market is booming! A groundbreaking efficiency record in electrolysis is revolutionizing production costs. At the same time, the world's first commercial hydrogen flight connection is launching, proving the technology's suitability for everyday use. This boom is confirmed by a European hydrogen auction, which underscores the immense competitiveness of green hydrogen with record results. These three powerful impulses are now also driving the established players. The developments at Nel ASA, dynaCERT, and Daimler Truck are particularly noteworthy.
Read
Commented by Armin Schulz on August 27th, 2025 | 07:05 CEST
China's leverage: Why Rheinmetall is struggling, European Lithium is benefiting, and BYD remains confident
The next wave of global conflicts will not be fought with weapons, but with export licenses. At the heart of this geopolitical struggle are critical metals without which no high-tech weapon, electric vehicle, or wind turbine can function. China's recent tightening of export restrictions has exposed the West's brutal dependency, forcing governments and corporations alike to rapidly rethink and realign their supply chains. While some companies are fighting to secure their supply chains, others are consolidating their sources or celebrating their monopolistic position. Three companies exemplify this dichotomy: the recently pressured defense giant Rheinmetall, the rare earth and lithium beneficiary European Lithium, and the Chinese giant BYD.
Read
Commented by Armin Schulz on August 26th, 2025 | 07:10 CEST
The blueprint for AI-driven drug discovery: How Evotec, NetraMark Holdings, and BioNTech are leveraging new opportunities
The pharmaceutical industry is undergoing a revolution. Artificial intelligence is reducing drug discovery times from years to months and dramatically increasing hit rates. Data-driven predictions and virtual simulations are increasingly replacing costly trial-and-error approaches. This technological leap is already generating concrete successes and massive competitive advantages for pioneers who implemented their digitalization strategies early on. Most recently, an AI-designed drug advanced to clinical trials in record time. Three companies driving this change and reaping its benefits are Evotec, NetraMark Holdings, and BioNTech.
Read
Commented by Armin Schulz on August 25th, 2025 | 07:30 CEST
Defense, tungsten, algorithms: Invest in market leaders Rheinmetall, Almonty Industries, and Palantir
In a world undergoing geopolitical upheaval, three key sectors are coming into focus: modern defense technology, critical raw materials, and strategic data analysis. While defense giants are benefiting from rising military budgets, raw material pioneers are satisfying the hunger for materials in the high-tech and defense industries. At the same time, data analysis is monetizing this new complexity for both companies and government security agencies. The successful convergence of these sectors is creating unique growth opportunities. Anyone looking to invest in the defense and security sector should keep an eye on market leaders Rheinmetall, Almonty Industries, and Palantir. They benefit from stability, innovative strength, and reliable growth opportunities.
Read
Commented by Armin Schulz on August 21st, 2025 | 07:10 CEST
Overvaluations in pharma and biotech reduced – Novo Nordisk, BioNxt Solutions, and Bayer are NOW in focus
Following the drastic market correction since the waning of the COVID-19 pandemic, the pharma and biotech sectors now offer more rationalized valuations and real opportunities. Instead of speculative hype, solid pipelines, clinical results, and disruptive technologies are what count today. Artificial intelligence is revolutionizing drug development, accelerating processes, and creating measurable competitive advantages. This new reality makes companies that are mastering their digital transformation particularly promising candidates. However, it is important to take a close look at each company. That is why we are examining three exciting companies today where there is a lot going on: Novo Nordisk, BioNxt Solutions, and Bayer.
Read
Commented by Armin Schulz on August 19th, 2025 | 07:15 CEST
TUI, naoo, Puma – Three stocks whose digital revolution could double your portfolio
If you are not thinking digitally today, you are losing out. Period. Progressive companies do not just use AI and data; they link them to their core business. The result? Less friction, more room for growth, and customers who come back. These companies are not only leaving the competition behind, but they are also becoming magnets for savvy investors. Let's take a closer look at how TUI, naoo, and Puma are intelligently using their data, AI, and platforms to make their businesses fit for the future.
Read
Commented by Armin Schulz on August 18th, 2025 | 07:10 CEST
Hydrogen renaissance – Plug Power, Pure Hydrogen, and Nel ASA want a slice of the USD 680 billion pie
The global hydrogen economy is on the verge of a breakthrough. This is being driven by multi-billion-dollar decarbonization targets, the quest for independence from fossil fuels, and falling costs for renewable energy. Demand could increase fivefold by 2050. By 2035, 60% of energy demand is expected to come from clean production, supported by over 1,500 large-scale projects worldwide. Despite gaps between planning and implementation, investments of up to USD 680 billion in the coming years and groundbreaking industry contracts signal an irreversible transformation. Amid this momentum, three key players are strategically positioning themselves: Plug Power, Pure Hydrogen, and Nel ASA.
Read
Commented by Armin Schulz on August 15th, 2025 | 07:00 CEST
War and raw material shortages = Your profit: How Rheinmetall, Almonty Industries, and RENK are now cashing in
The global security architecture is collapsing, and with it, the rules of the game in the defense industry are changing. While superpowers like the US are pumping billions into strategic raw materials to break critical import dependencies, resource security is becoming the new currency of military strength. Tungsten, rare earths, and high-performance metals are now decisive factors in technological sovereignty. Those who take advantage of this shift stand to benefit from unprecedented government initiatives. Three companies are positioning themselves decisively in this area: Rheinmetall, Almonty Industries, and RENK.
Read